(Q74447937)

English

Successful treatment with a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) for a patient with relapsed mantle cell lymphoma who developed a human anti-chimeric antibody

scientific article published on 01 July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Successful treatment with a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) for a patient with relapsed mantle cell lymphoma who developed a human anti-chimeric antibody (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

T Maeda

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Y Yamada

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Tawara

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Yamasaki

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Y Yakata

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Tsutsumi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Y Onimaru

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Kamihira

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Tomonaga

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

International Journal of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

74

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

70-75

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

https://scigraph.springernature.com/pub.10.1007/bf02982552

0 references

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytological and functional criteria for the classification of malignant lymphomata

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mantle cell lymphoma: a retrospective study of 121 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11530808

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02982552

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74447937&oldid=1947266808"